Bharat Biotech in-licences GSK's Shigella vaccine candidate |...

Dununu.com Dununu

Patrocinado

Bharat Biotech in-licences GSK's Shigella vaccine candidate

RSS Feed Business

Postado

53

Bharat Biotech has in-licensed GSK's Shigella vaccine candidate, altSonflex1-2-3, aimed at combating Shigellosis in young children in low- and middle-income countries. Following promising early-stage trials by GSK, Bharat Biotech will advance the vaccine through Phase-III trials, regulatory processes, and large-scale production. This collaboration strengthens Bharat Biotech's portfolio of vaccines against diarrheal infections.

Read Full Article

Faça o login para curtir, compartilhar e comentar!

Education Minister aims to pass School Education Bill by June 29

KATHMANDU: Minister for Education, Science, and Technology, Raghujee Pant, announced today that...

Por 0 1

Air India plane crash: All Boeing 787s to be inspected; DNA testing of victims being done - key takeaways from Centre's 1st briefing on crash

Por 0 12

RBI may cut rates further after brief pause; more liquidity requirement in second half of FY26: Report

The Reserve Bank of India (RBI) is likely to cut interest rates further after a temporary pause,...

Por 0 13

Demand for coffee seedlings surges in gulmi, supply falls short

GULMI: The demand for coffee seedlings has surged in Gulmi, creating a significant supply gap at...

Por 0 28

Katrina Kaif and Vicky Kaushal's love story

Katrina Kaif and Vicky Kaushal's romance, now admired in Bollywood, began subtly. Their first...

Por 0 34